RSS
4 Jan 2022

Chemomab Therapeutics Names Jack Lawler Vice President of Global Clinical Development Operations

Author: admintech | Filed under: Press Release

TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today named Jack…

This entry was posted on Tuesday, January 4th, 2022 at 7:10 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»